Versant Venture Management’s Minerva Surgical, Inc. Common Stock UTRS Stock Holding History

Versant Venture Management’s Portfolio UTRS Stock Details UTRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,184	Closed	-$275K	–	8
2023 Q3	$275K	Sell	4,184 -79,501	-95%	-$362K	0.15%	8
2023 Q2	$429K	Hold	83,685	–	–	0.51%	8
2023 Q1	$367K	Hold	83,685	–	–	0.77%	7
2022 Q4	$374K	Hold	83,685	–	–	0.77%	7
2022 Q3	$1.33M	Hold	83,685	–	–	2.27%	7
2022 Q2	$3.93M	Hold	83,685	–	–	6.03%	5
2022 Q1	$7.53M	Hold	83,685	–	–	7.52%	6
2021 Q4	$8.6M	Buy	+83,685	New	+$11.9M	4.6%	8

Versant Venture Management's UTRS Position: Q4 2023 in Review

Versant Venture Management sold out of Minerva Surgical, Inc. Common Stock (UTRS) in Q4 2023, closing a stake of 4,184 shares — an estimated $275K sold.

Versant Venture Management first reported a position in UTRS in Q4 2021 and held it in 8 quarters. The position peaked at $8.6M in Q4 2021. 0 funds tracked by Wall St. Rank hold UTRS as of Q4 2023.

Versant Venture Management reported no remaining Minerva Surgical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Versant Venture Management sold 4,184 Minerva Surgical, Inc. Common Stock shares in Q4 2023, an estimated $275K.
Versant Venture Management first reported a position in Minerva Surgical, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
Versant Venture Management's Minerva Surgical, Inc. Common Stock position peaked at $8.6M in Q4 2021.
0 funds tracked by Wall St. Rank held Minerva Surgical, Inc. Common Stock as of Q4 2023.

Based on Versant Venture Management's 13F filing for Q4 2023, filed 8 Feb 2024.